Dyslipidemia in Human Immunodeficiency Virus Disease
Journal of the American College of Cardiology · 2023-07 · 82 (2) · 171-181
DOI: 10.1016/j.jacc.2023.04.050 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of the American College of Cardiology, 2023-07. Verfasst von Dinesh K Kalra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, University of Louisville, Louisville, Kentucky, USA. Electronic address: dinesh.kalra@louisville.edu. Hauptthemen laut MEDLINE: Cardiovascular Diseases, HIV Infections, Dyslipidemias. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
The advent of newer and better tolerated antiretroviral therapy has progressively shortened the life expectancy gap between people living with HIV (PWH) and the general population. However, in this aging cohort, cardiovascular disease is now a significant cause of morbidity and mortality despite advances in cardiac care. Therefore, it is critical to assess and treat all cardiovascular disease risk factors, including dyslipidemia, early and aggressively in PWH. Data are not as robust regarding the pathogenesis and management of dyslipidemia in PWH, with most evidence being extrapolated from the general uninfected population. In this review the authors describe the current understanding of the pathophysiology of HIV and antiretroviral therapy-induced dyslipidemia, and the approach to risk assessment and management, given that drug-drug interactions remain an important consideration in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiology, University of Louisville, Louisville, Kentucky, USA. Electronic address: dinesh.kalra@louisville.edu.
- Division of Cardiology, University of Louisville, Louisville, Kentucky, USA.
- Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Center for Cardiovascular Disease Prevention, Baylor Scott & White Health, Plano, Texas, USA.
- Section of Cardiovascular Research, Baylor College of Medicine and Section of Cardiology, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
- Division of Cardiovascular Medicine, Oregon Health Sciences University, Portland, Oregon, USA.
Zitieren
APA
Kalra, D. K., Vorla, M., Michos, E. D., Agarwala, A., Virani, S., Duell, P. B., & Raal, F. J. (2023). Dyslipidemia in Human Immunodeficiency Virus Disease. Journal of the American College of Cardiology, 82(2), 171-181. https://doi.org/10.1016/j.jacc.2023.04.050
Vancouver
Kalra DK, Vorla M, Michos ED, Agarwala A, Virani S, Duell PB, et al. Dyslipidemia in Human Immunodeficiency Virus Disease. Journal of the American College of Cardiology. 2023;82(2):171-181. doi:10.1016/j.jacc.2023.04.050
BibTeX
@article{Kalra2023,
author = {Kalra, Dinesh K and Vorla, Mounica and Michos, Erin D and Agarwala, Anandita and Virani, Salim and Duell, P Bart and Raal, Frederick J},
title = {Dyslipidemia in Human Immunodeficiency Virus Disease},
journal = {Journal of the American College of Cardiology},
year = {2023},
volume = {82},
number = {2},
pages = {171--181},
doi = {10.1016/j.jacc.2023.04.050}
}
EUVIMED